About: Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Synthesis, crystal structures and biological activities for the new chlorobridged mixed valence CuI/CuII coordination polymer [CuIIcyclam][CuICl3] 1 and [H4cyclam][Cu2 I Cl6] 2 are reported. Compound 1 crystallizes in the orthorhombic system, space group Pccn. Its crystal structure consists of one-dimensional polymer CuIIcyclam–Cl–CuI–Cl–CuIIcyclam. Compound 2 is monoclinic (P21/n)with the tetraprotonated cyclam H4cyclam(4+) in (3,4,3,4)-B conformation. Compound 1 was tested to understand its influence on enzyme activity, immunomodulation as well as its toxicity and antiglycation potential. Its effect was significant as immunomodulatory and inhibitory activity against b-glucuronidase enzyme. Synthesis, crystal structures and biological activities for the new chlorobridged mixed valence CuI/CuII coordination polymer [CuIIcyclam][CuICl3] 1 and [H4cyclam][Cu2 I Cl6] 2 are reported. Compound 1 crystallizes in the orthorhombic system, space group Pccn. Its crystal structure consists of one-dimensional polymer CuIIcyclam–Cl–CuI–Cl–CuIIcyclam. Compound 2 is monoclinic (P21/n)with the tetraprotonated cyclam H4cyclam(4+) in (3,4,3,4)-B conformation. Compound 1 was tested to understand its influence on enzyme activity, immunomodulation as well as its toxicity and antiglycation potential. Its effect was significant as immunomodulatory and inhibitory activity against b-glucuronidase enzyme. (en)
Title	Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies (en)
skos:prefLabel	Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies (en)
skos:notation	RIV/68378271:_____/12:00388275!RIV13-AV0-68378271
http://linked.open...avai/riv/aktivita	Z
http://linked.open...avai/riv/aktivity	Z(AV0Z10100521)
http://linked.open...iv/cisloPeriodika	12
http://linked.open...vai/riv/dodaniDat	2013
http://linked.open...aciTvurceVysledku	Fejfarová, Karla Dušek, Michal
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Fyzikální ústav AV ČR, v. v. i.
http://linked.open...dnocenehoVysledku	175466
http://linked.open...ai/riv/idVysledku	RIV/68378271:_____/12:00388275
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	mixed valence; copper(I/II) complexes; halocuprates; tetraazacyclotetradecane; x-ray structures; beta-glucuronidase; enzyme inhibition (en)
http://linked.open.../riv/klicoveSlovo	beta-glucuronidase copper(I/II) complexes halocuprates mixed valence tetraazacyclotetradecane x-ray structures enzyme inhibition
http://linked.open...odStatuVydavatele	US - Spojené státy americké
http://linked.open...ontrolniKodProRIV	[B434CA6B60AC]
http://linked.open...i/riv/nazevZdroje	Medicinal Chemistry Research
http://linked.open...in/vavai/riv/obor	BM
http://linked.open...ichTvurcuVysledku	2 (xsd:int)
http://linked.open...cetTvurcuVysledku	12 (xsd:int)
http://linked.open...UplatneniVysledku	2012
http://linked.open...v/svazekPeriodika	21
http://linked.open...iv/tvurceVysledku	Dušek, Michal Fejfarová, Karla El Bali, B. Lachkar, M. Bezgour, A. Halime, I. Choudhary, M. I. Khan, A. Marasini, B. P. Noreen, S. Rasheed, S. Siddiq, S.
http://linked.open...ain/vavai/riv/wos	000310030200037
http://linked.open...n/vavai/riv/zamer	Physics and technology of nanostructures, surfaces and thin films
issn	1054-2523
number of pages	11 (xsd:int)
http://bibframe.org/vocab/doi	10.1007/s00044-011-9968-7

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 112 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software